276 related articles for article (PubMed ID: 16204339)
21. Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats.
Ozturan KE; Yucel I; Kocoglu E; Cakici H; Guven M
J Orthop Res; 2010 Oct; 28(10):1368-72. PubMed ID: 20839321
[TBL] [Abstract][Full Text] [Related]
22. Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial.
Wiesner G; Braun SL; Gruber M; Gertler R; Lange R; Tassani P; Martin K
J Antimicrob Chemother; 2012 Jan; 67(1):230-3. PubMed ID: 21972268
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
Pelletier LL; Durack DT; Petersdorf RG
J Clin Invest; 1975 Aug; 56(2):319-30. PubMed ID: 1150874
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis.
Durack DT; Starkebaum MK; Petersdorf RG
J Lab Clin Med; 1977 Jul; 90(1):171-9. PubMed ID: 406336
[No Abstract] [Full Text] [Related]
25. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.
Chen CW; Ming CC; Ma CJ; Shan YS; Yeh YS; Wang JY
Surg Infect (Larchmt); 2013 Aug; 14(4):389-96. PubMed ID: 23859673
[TBL] [Abstract][Full Text] [Related]
26. Experimental Staphylococcus epidermidis endocarditis in rabbit model.
Shamsuddin D; Tuazon CU; Miller H; Shamsuddin AK; Friedman D
Arch Pathol Lab Med; 1983 Mar; 107(3):141-3. PubMed ID: 6687530
[TBL] [Abstract][Full Text] [Related]
27. Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis.
Tsitsika A; Pefanis A; Perdikaris GS; Donta I; Karayiannakos P; Giamarellou H
Antimicrob Agents Chemother; 2000 Jun; 44(6):1754-6. PubMed ID: 10817749
[TBL] [Abstract][Full Text] [Related]
28. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
Kanellakopoulou K; Galanopoulos I; Soranoglou V; Tsaganos T; Tziortzioti V; Maris I; Papalois A; Giamarellou H; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2009 Apr; 33(4):354-9. PubMed ID: 19097865
[TBL] [Abstract][Full Text] [Related]
29. Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.
Kalteis T; Beckmann J; Schröder HJ; Handel M; Grifka J; Lehn N; Lerch K
Acta Orthop; 2006 Apr; 77(2):315-9. PubMed ID: 16752296
[TBL] [Abstract][Full Text] [Related]
30. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
[TBL] [Abstract][Full Text] [Related]
31. Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.
Ober MC; Hoppe-Tichy T; Köninger J; Schunter O; Sonntag HG; Weigand MA; Encke J; Gutt C; Swoboda S
J Antimicrob Chemother; 2009 Nov; 64(5):1091-5. PubMed ID: 19734170
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
[TBL] [Abstract][Full Text] [Related]
33. Moxifloxacin prophylaxis in neutropenic patients.
von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
[TBL] [Abstract][Full Text] [Related]
34. Moxifloxacin and torsade de pointes.
Dale KM; Lertsburapa K; Kluger J; White CM
Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
36. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
37. Experimental endocarditis in rabbits. 2. Course of untreated Streptococcus faecalis infection.
Gutschik E; Christensen N
Acta Pathol Microbiol Scand B; 1978 Aug; 86(4):223-8. PubMed ID: 99977
[TBL] [Abstract][Full Text] [Related]
38. Treatment of implant-associated infections with moxifloxacin: an animal study.
Kalteis T; Beckmann J; Schröder HJ; Schaumburger J; Linde HJ; Lerch K; Lehn N
Int J Antimicrob Agents; 2006 May; 27(5):444-8. PubMed ID: 16621461
[TBL] [Abstract][Full Text] [Related]
39. Role of oral bacterial flora in calcific aortic stenosis: an animal model.
Cohen DJ; Malave D; Ghidoni JJ; Iakovidis P; Everett MM; You S; Liu Y; Boyan BD
Ann Thorac Surg; 2004 Feb; 77(2):537-43. PubMed ID: 14759434
[TBL] [Abstract][Full Text] [Related]
40. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
